Abstract
The authors report the case of a chronic myeloid leukemia (CML) patient submitted to allogenic bone marrow transplantation, who had probably never entered complete remission. The disease was reactivated as a granulocytic sarcoma, next to a platinum plate installed to correct a tibia fracture 11 years earlier. Its final event was a myeloid Ph1 + blastic crisis that was unsuccessfully treated with high doses of sc interferon and citarabine.
MeSH terms
-
Adult
-
Antineoplastic Agents / therapeutic use
-
Blast Crisis / drug therapy
-
Bone Marrow Transplantation / adverse effects*
-
Cytarabine / therapeutic use
-
Fatal Outcome
-
Female
-
Humans
-
Interferons / therapeutic use
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / etiology
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
-
Leukemia, Myeloid / etiology
-
Recurrence
Substances
-
Antineoplastic Agents
-
Cytarabine
-
Interferons